Fujifilm, Takeda Partner on Regenerative Medicine Therapies

Fujifilm Global and Takeda Oncology recently announced a collaboration to develop regenerative medicine therapies for the treatment of heart failure using induced pluripotent stem cell (iPSC)-derived cardiomyocytes.

This partnership grants Takeda the right of first negotiation to collaboratively and globally commercialize regenerative medicine products using cardiomyocytes derived from iPSCs.

Aiichiro Hiruma, general manager of Regenerative Medicine Division at Fujifilm, said in a company press release, “In addition to establishing new treatment methods for patients with heart disease, Fujifilm and Takeda will contribute to the elevation of regenerative medication business to the industrial stage by applying our engineering technologies to manufacture high-quality cells safely and efficiently.”

Continue Reading.


Osteo Science Foundation
1650 Market Street, Suite 3600
Philadelphia, PA 19103
855-891-2877 Toll Free

Osteo Science Foundation is an independent, privately funded 501 (c) (3) non-profit organization.


%d bloggers like this: